• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
FIGURE 86. Cost-effectiveness acceptability curve for each intervention following sensitivity analysis over 10 years with rates for positive margin status set at OR 0.955 (200 procedures using the least expensive procurement plan for the robotic system).

FIGURE 86Cost-effectiveness acceptability curve for each intervention following sensitivity analysis over 10 years with rates for positive margin status set at OR 0.955 (200 procedures using the least expensive procurement plan for the robotic system)

From: Appendix 15, Density charts describing the distribution of total costs and quality-adjusted life-years for the cohort of modelled men for each analysis presented

Cover of Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer
Systematic Review and Economic Modelling of the Relative Clinical Benefit and Cost-Effectiveness of Laparoscopic Surgery and Robotic Surgery for Removal of the Prostate in Men with Localised Prostate Cancer.
Health Technology Assessment, No. 16.41.
Ramsay C, Pickard R, Robertson C, et al.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.